Purchases and Sales Made in Q4 2022 in Ngm Biopharmaceuticals Inc (NGM)
This table provides information about the institutional ownership of Ngm Biopharmaceuticals Inc (NGM) during Q4 2022. The information is specifically focused on institutions that hold shares of NGM BIOPHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 09, 2023
Q4 2022
|
Citigroup Inc
|
SELL
|
- |
-8.02K- 78.9% |
$27.3K - $104K
|
2.14K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-16.3K- 11.71% |
$55.6K - $211K
|
123K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-19K- 7.23% |
$64.8K - $246K
|
244K
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Raymond James Financial Services Advisors, Inc.
St. Petersburg, FL |
SELL
|
- |
-31.5K- 37.06% |
$107K - $407K
|
53.4K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-41.5K- 57.31% |
$141K - $536K
|
30.9K
$0
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-42.5K- 68.59% |
$145K - $549K
|
19.4K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Pura Vida Investments, LLC
New York, NY |
SELL
|
- |
-52.5K- 38.72% |
$179K - $679K
|
83.2K
$0
|
|
|
Feb 08, 2023
Q4 2022
|
Raymond James & Associates
St Petersburg, FL |
SELL
|
- |
-67.4K- 70.45% |
$230K - $872K
|
28.3K
$0
|
|
|
Jan 12, 2023
Q4 2022
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-116K- 66.4% |
$397K - $1.5M
|
58.9K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-151K- 17.65% |
$515K - $1.95M
|
705K
$0
|
|
|
Feb 09, 2023
Q4 2022
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-240K- 30.46% |
$818K - $3.1M
|
548K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-268K- 91.03% |
$913K - $3.46M
|
26.4K
$0
|
|
|
Feb 14, 2023
Q4 2022
|
Axa S.A.
Paris, I0 |
SELL
|
- |
-292K- 72.0% |
$996K - $3.78M
|
114K
$0
|